Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorder

Journal of Psychiatry and Neuroscience

Volumn 35, Issue 1, 2010, Pages 55-58

  Romanos, Marcel ^a   Weise, David ^a,b   Schliesser, Mira ^a   Schecklmann, Martin ^a   Löffler, Julia ^a,c   Warnke, Andreas ^a   Gerlach, Manfred ^a   Classen, Joseph ^a,b   Mehler Wex, Claudia ^c  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ECHOGRAPHY; EFFECT SIZE; FEMALE; HUMAN; MALE; NIGRONEOSTRIATAL SYSTEM; SCHOOL CHILD; SEX DIFFERENCE; STRUCTURE ANALYSIS; SUBSTANTIA NIGRA;

EID: 75449113400     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: 10.1503/jpn.090044     Document Type: Article

References (22)

1. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-8.
2. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005;366:237-48.
3. Mehler-Wex C, Riederer P, Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox Res 2006;10:167-79.
4. Becker G, Seufert J, Bogdahn U, et al. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995;45:182-4.
5. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008;7:1044-55.
6. Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children - present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997;36:980-8.
7. Achenbach TM. Manual for the child behavior checklist/4-18 and 1991 profile. Burlington (VT): University of Vermont; 1991.
8. Döpfner M, Lehmkuhl J. Diagnostik-System für psychische Störungen im Kindes- und Jugendalter nach ICD-10 und DSM-IV. Bern: Huber Verlag; 1998.
9. Stiensmeier-Pelster J, Schürmann M, Duda K. Depressions-Inventar für Kinder und Jugendliche (DIKJ). Göttingen: Hogrefe; 1989.
10. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999;53:1026-31.
11. Walter U, Behnke S, Eyding J, et al. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 2007;33:15-25.
12. Iova A, Garmashov A, Androuchtchenko N, et al. Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson's disease. J Neurol 2004;251:1451-4.
13. Rubia K. Neuro-anatomic evidence for the maturational delay hypothesis of ADHD. Proc Natl Acad Sci U S A 2007;104:19663-4.
14. Qiu A, Crocetti D, Adler M, et al. Basal ganglia volume and shape in children with attention deficit hyperactivity disorder. Am J Psychiatry 2009;166:74-82.
15. Ellison-Wright I, Ellison-Wright Z, Bullmore E. Structural brain change in attention deficit hyperactivity disorder identified by meta-analysis. BMC Psychiatry 2008;8:51.
16. Weise D, Lorenz R, Schliesser M, et al. Substantia nigra echogenicity: a structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Mov Disord 2009;24:1669-75.
17. Berg D, Jabs B, Merschdorf U, et al. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 2001;50:463-7.
18. Berg D, Roggendorf W, Schröder U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002; 59: 999-1005.
19. Berg D, Gerlach M, Youdim MB, et al. Brain iron pathways and their relevance to Parkinson's disease. J Neurochem 2001;79:225-36.
20. Berg D. Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms. Neurochem Res 2007;32:1646-54.
21. Oner P, Oner O. Relationship of ferritin to symptom ratings children with attention deficit hyperactivity disorder: effect of comorbidity. Child Psychiatry Hum Dev 2008;39:323-30.
22. Walter U, Hoeppner J, Prudente-Morrissey L, et al. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 2007;130:1799-807.